Henrik H. El Ali

Henrik H. El Ali serves as an Associate Professor in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. His research is centered at the intersection of molecular imaging and physiological systems, with particular focus on circulation, kidney and lung functions. He maintains an active research profile through the Cluster for Molecular Imaging and Department of Clinical Physiology, Nuclear Medicine and PET.

His primary research interests include Molecular Imaging, Positron Emission Tomography (PET), and Cardiovascular Diseases, with significant contributions to cancer imaging and nuclear medicine applications. His work spans physiological mechanisms in circulation, kidney function, and pulmonary systems, often employing advanced imaging techniques to investigate disease pathways.

Analysis of his publication record reveals a strong trend toward translational medical imaging research, particularly in stroke assessment, cancer treatment monitoring, and cardiovascular physiology. His recent work demonstrates increasing integration of machine learning techniques with physiological measurements, as evidenced by his 2025 paper using random forest analysis for lung disease assessment.

While specific scientific awards aren't documented in the available materials, his research has garnered significant attention with multiple papers showing substantial Mendeley readership and citation metrics. His work on stroke biomarkers and cancer imaging appears particularly influential within the medical imaging community.

Dr. El Ali maintains active research collaborations across multiple institutions, as indicated by his co-authorship patterns and the international scope of his publications. His laboratory work focuses on developing and applying novel imaging techniques to address critical questions in cardiovascular and pulmonary medicine. Current projects appear to emphasize non-invasive monitoring of disease progression and treatment response, particularly in stroke and cancer contexts.